Radiation Therapy Oncology Group
BiotechPhiladelphia, Pennsylvania, United States · Est. 1968
The Radiation Therapy Oncology Group (RTOG) is a cooperative research organization that conducts clinical trials for cancer treatment, primarily focusing on radiation therapy protocols and outcomes.
0
Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
0
Indications↗
Distinct diseases across all programs
117
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Key Events
Oct 22, 2026TrialA Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Jul 21, 2026TrialPhase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer
Nov 14, 2025FDALupron — LUPRON DEPOT-PED KIT
Sep 23, 2025FDALupron — LUPRON DEPOT-PED KIT
Sep 10, 2025FDALupron — LUPRON DEPOT
Sep 10, 2025FDALupron — LUPRON DEPOT
Sep 10, 2025FDALupron — LUPRON DEPOT
Sep 10, 2025FDALupron — LUPRON DEPOT
Details
Company Info
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Therapeutic Focus
OncologyRadiation TherapyCancer Treatment
Regulatory
Regulatory Timeline
20211 event
FDANov 12
Lupron — LUPRON DEPOT-PED KIT
Application NDA020263
20223 events
FDAApr 22
Lupron — LUPRON DEPOT-PED KIT
Application NDA020263
FDAApr 18
Lupron — LUPRON DEPOT
Application NDA019732
FDAApr 18
Lupron — LUPRON DEPOT
Application NDA020517
20235 events
FDADec 4
Lupron — LUPRON DEPOT
Application NDA020517
FDADec 4
Lupron — LUPRON DEPOT-PED KIT
Application NDA020263
FDADec 4
Lupron — LUPRON DEPOT
Application NDA019732
FDAApr 14
Lupron — LUPRON DEPOT-PED KIT
Application NDA020263
FDAJan 27
Lupron — LUPRON DEPOT
Application NDA020011
20242 events
FDAMar 21
Lupron — LUPRON DEPOT
Application NDA020517
FDAMar 21
Lupron — LUPRON DEPOT
Application NDA019732
20259 events
FDANov 14
Lupron — LUPRON DEPOT-PED KIT
Application NDA020263
FDASep 23
Lupron — LUPRON DEPOT-PED KIT
Application NDA020263
FDASep 10
Lupron — LUPRON DEPOT
Application NDA020011
FDASep 10
Lupron — LUPRON DEPOT
Application NDA020011
FDASep 10
Lupron — LUPRON DEPOT
Application NDA020708
FDASep 10
Lupron — LUPRON DEPOT
Application NDA020708
FDAAug 18
Lupron — LUPRON DEPOT
Application NDA019732
FDAAug 18
Lupron — LUPRON DEPOT
Application NDA020517
FDAMay 22
Lupron — LUPRON DEPOT-PED KIT
Application NDA020263
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)